# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
On May 7, 2024, Dr. Jonathan Rothbard resigned as Chief Scientific Officer of the Company
180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that the Company ...